AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12354335 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Number of subjects: 46
Study 12354335 — intervention group
Group type: COMPARATOR
Intervention: Conventional chest physiotherapy (CPT)
Number of subjects: 46
Study 10195534 — intervention group
Group type: EXPERIMENTAL
Intervention: Active millimeter wave generator (MW)
Number of subjects: 12
Study 10195534 — intervention group
Group type: COMPARATOR
Intervention: Disabled sham generator (control)
Number of subjects: 12
Study 7786700 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen-sealed Dacron graft
Number of subjects: 20
Study 7786700 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin-impregnated Dacron graft
Number of subjects: 20
Study 2179479 — intervention group
Group type: EXPERIMENTAL
Intervention: multidrug chemotherapy schedule with VM26 and AraC
Number of subjects: 21
Study 2179479 — intervention group
Group type: COMPARATOR
Intervention: multidrug chemotherapy schedule without VM26 and AraC
Number of subjects: 21
Study 7428403 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cephazolin sodium (1 g) given intramuscularly
Number of subjects: 690
Study 7428403 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cephazolin sodium (1 g) given intravenously
Number of subjects: 690
Study 7428403 — intervention group
Group type: COMPARATOR
Intervention: No treatment or placebo
Number of subjects: 690
Study 31005919 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided physical exercise and dietary therapy
Number of subjects: 10
Study 28374645 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine-QR (B-QR)
Number of subjects: 60
Study 28374645 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine-QR (B-QR) in high-dose insulin subset
Number of subjects: 60
Study 28374645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25896104 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 5 mg twice daily for three days
Number of subjects: 43
Study 25896104 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical capsules for three days)
Number of subjects: 43
Study 24075920 — intervention group
Group type: EXPERIMENTAL
Intervention: rHA 135 μg
Number of subjects: 392
Study 24075920 — intervention group
Group type: EXPERIMENTAL
Intervention: rHA 45 μg
Number of subjects: 392
Study 24075920 — intervention group
Group type: EXPERIMENTAL
Intervention: rHA 45 μg with GLA/SE
Number of subjects: 392
Study 24075920 — intervention group
Group type: EXPERIMENTAL
Intervention: rHA 15 μg with GLA/SE
Number of subjects: 392
Study 24075920 — intervention group
Group type: EXPERIMENTAL
Intervention: rHA 7.5 μg with GLA/SE
Number of subjects: 392
Study 24075920 — intervention group
Group type: EXPERIMENTAL
Intervention: rHA 3.8 μg with GLA/SE
Number of subjects: 392
Study 24075920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 24075920 — intervention group
Group type: COMPARATOR
Intervention: rHA alone
Number of subjects: 392
Study 21430194 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding (or exclusively breastfeeding) at the beginning of each follow-up interval
Number of subjects: 17046
Study 21430194 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 17046
Study 19250094 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocardiogram-based algorithm
Number of subjects: 100
Study 17277910 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 40
Study 17277910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 14734701 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 9422
Study 14734701 — intervention group
Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 9422
Study 11708732 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality distraction
Number of subjects: 2
Study 11708732 — intervention group
Group type: EXPERIMENTAL
Intervention: Movie distraction
Number of subjects: 2
Study 11708732 — intervention group
Group type: COMPARATOR
Intervention: No distraction
Number of subjects: 2
Study 9315419 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9 (N-9)
Number of subjects: 12
Study 7936969 — intervention group
Group type: EXPERIMENTAL
Intervention: Lighter balls (Tachikara Volley Lite) during skills progressions
Number of subjects: 72
Study 7936969 — intervention group
Group type: COMPARATOR
Intervention: Regulation balls during skills progressions
Number of subjects: 72
Study 3358884 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride (10 g)
Number of subjects: 6
Study 3358884 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (8 g)
Number of subjects: 6
Study 3358884 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (8 g)
Number of subjects: 6
Study 3358884 — intervention group
Group type: COMPARATOR
Intervention: Water only
Number of subjects: 6
Study 31146613 — intervention group
Group type: EXPERIMENTAL
Intervention: RBAC (3 grams/day for 6 months)
Number of subjects: 47
Study 31146613 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 grams/day for 6 months)
Number of subjects: 47
Study 30337307 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery
Number of subjects: 0
Study 30337307 — intervention group
Group type: COMPARATOR
Intervention: Bronchoscopic lung volume reduction with endobronchial valves
Number of subjects: 0
Study 27316668 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 146
Study 27316668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 24725374 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First intervention
Number of subjects: 301
Study 24725374 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative data
Number of subjects: 301
Study 22282257 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer aided cervical vertebra landmarking (CACVL)
Number of subjects: 120
Study 22282257 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic experts (OE) group
Number of subjects: 120
Study 22282257 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic novices (ON) group
Number of subjects: 120
Study 19937954 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation
Number of subjects: 244
Study 19937954 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 244
Study 19059175 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly simulated and critiqued oral examinations (MSCE) from 2003 to 2006 classes
Number of subjects: 48
Study 19059175 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (2001 and 2002 classes) without MSCE
Number of subjects: 48
Study 15857065 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride/stannous fluoride (AmF/SnF2) mouthwash
Number of subjects: 33
Study 15857065 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CHX) mouthwash
Number of subjects: 33
Study 12215465 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat (40 or 80 mg)
Number of subjects: 32
Study 12215465 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril/Hydrochlorothiazide (FOS/HCTZ; 20 and 12.5 mg)
Number of subjects: 32
Study 12215465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 10405084 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly depressed patients
Number of subjects: 40
Study 10405084 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 40
Study 7725767 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg PGE2 intracervical gel
Number of subjects: 79
Study 7725767 — intervention group
Group type: COMPARATOR
Intervention: 3 mg PGE2 vaginal tablet
Number of subjects: 79
Study 2175140 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-endorphin infusion at 1 microgram.kg‐1.min‐1
Number of subjects: 7
Study 2175140 — intervention group
Group type: COMPARATOR
Intervention: placebo (normal saline) infusion
Number of subjects: 7
Study 2175140 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-endorphin infusion
Number of subjects: 7
Study 6994086 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 16
Study 6994086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30885626 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial cultivation with sonication pretreatment in 4 sVHD patients
Number of subjects: 25
Study 30885626 — intervention group
Group type: EXPERIMENTAL
Intervention: Metagenome analysis
Number of subjects: 25
Study 30885626 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological staining
Number of subjects: 25
Study 29068865 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Integrated Movement Enhancement (DIME)
Number of subjects: 1068
Study 29068865 — intervention group
Group type: COMPARATOR
Intervention: Army Preparation Drill (PD)
Number of subjects: 1068
Study 25731923 — intervention group
Group type: EXPERIMENTAL
Intervention: BREAKS (2-min of treadmill walking at 3.2 km/h every 20 min for a total of 17 breaks/day)
Number of subjects: 19
Study 25731923 — intervention group
Group type: COMPARATOR
Intervention: SIT (7-h days of uninterrupted sitting)
Number of subjects: 19
Study 25731923 — intervention group
Group type: EXPERIMENTAL
Intervention: BREAKS
Number of subjects: 19
Study 25731923 — intervention group
Group type: COMPARATOR
Intervention: SIT
Number of subjects: 19
Study 25731923 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT and BREAKS
Number of subjects: 19
Study 24405833 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (20 mg/0.8 ml for patients <30 kg or 40 mg/0.8 ml for patients ≥30 kg, subcutaneous injection every 2 weeks)
Number of subjects: 154
Study 24405833 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.8 ml as appropriate according to body weight, subcutaneous injection every 2 weeks)
Number of subjects: 154
Study 23095489 — intervention group
Group type: COMPARATOR
Intervention: 1 session of HF-rTMS
Number of subjects: 21
Study 23095489 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 sessions of HF-rTMS
Number of subjects: 21
Study 23095489 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 21
Study 19708804 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypno-analgesia intervention
Number of subjects: 350
Study 19708804 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 350
Study 17709835 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose multi-detector row CT (30 mAs, 16 detector rows, 0.75-mm section thickness)
Number of subjects: 157
Study 17709835 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose multi-detector row CT
Number of subjects: 157
Study 15188172 — intervention group
Group type: COMPARATOR
Intervention: KLH feeding (50 and 250 mg) before immunization and booster in normal controls (n = 21)
Number of subjects: 45
Study 15188172 — intervention group
Group type: EXPERIMENTAL
Intervention: KLH feeding in patients with Crohn's disease (n = 12)
Number of subjects: 45
Study 15188172 — intervention group
Group type: EXPERIMENTAL
Intervention: KLH feeding in patients with ulcerative colitis (n = 13)
Number of subjects: 45
Study 15188172 — intervention group
Group type: COMPARATOR
Intervention: Immunization in normal controls (n = 21)
Number of subjects: 45
Study 15188172 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration in patients with Crohn's disease (n = 12)
Number of subjects: 45
Study 15188172 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration in patients with ulcerative colitis (n = 13)
Number of subjects: 45
Study 11552143 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically necessary dental services
Number of subjects: 0
Study 11552143 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental treatment interventions
Number of subjects: 0
Study 9688443 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of ticlopidine (1500 mg followed by 250 mg twice daily)
Number of subjects: 18
Study 9688443 — intervention group
Group type: COMPARATOR
Intervention: Standard ticlopidine treatment (250 mg twice daily)
Number of subjects: 18
Study 8010796 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia
Number of subjects: 20
Study 8010796 — intervention group
Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia
Number of subjects: 20
Study 2642691 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clomipramine hydrochloride (150 mg) and placebo tablets
Number of subjects: 22
Study 2642691 — intervention group
Group type: COMPARATOR
Intervention: Oral clomipramine hydrochloride (150 mg) and isotonic saline infusion
Number of subjects: 22
Study 2642691 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clomipramine hydrochloride (200 mg) and placebo tablets
Number of subjects: 22
Study 2642691 — intervention group
Group type: COMPARATOR
Intervention: Oral clomipramine hydrochloride (200 mg) and isotonic saline infusion
Number of subjects: 22
Study 10564 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 14
Study 10564 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 14
Study 31107823 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Donor Liver Transplantation (LDLT) for ALD
Number of subjects: 168
Study 25843498 — intervention group
Group type: COMPARATOR
Intervention: Home visit strategy by trained community health workers (CHWs) with five home visits (two during pregnancy and three after birth) and health facility strengthening.
Number of subjects: 0
Study 23451166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 749
Study 23451166 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle advice control
Number of subjects: 749
Study 23451166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention with ≥5% weight loss at one year
Number of subjects: 749
Study 21527582 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D levels 50 to <75 nmol/L
Number of subjects: 340
Study 21527582 — intervention group
Group type: COMPARATOR
Intervention: Serum 25(OH)D levels <25 nmol/L
Number of subjects: 340
Study 19160533 — intervention group
Group type: EXPERIMENTAL
Intervention: Eskimo Skin Care (oral oil formulation rich in natural stable fish oil)
Number of subjects: 24
Study 19160533 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study 16926560 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training with the Procedicus, computer-based, haptic simulator
Number of subjects: 20
Study 16926560 — intervention group
Group type: COMPARATOR
Intervention: Control group (no simulation training)
Number of subjects: 20
Study 14994317 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (mean dose 184.5 mg/d, range 130-234 mg/d)
Number of subjects: 39
Study 14994317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 14994317 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba
Number of subjects: 39
Study 11460611 — intervention group
Group type: EXPERIMENTAL
Intervention: Test Dentifrice (new calculus-inhibiting dentifrice with pyrophosphate, tripolyphosphate, copolymer in a 0.243% sodium fluoride/silica base)
Number of subjects: 128
Study 11460611 — intervention group
Group type: COMPARATOR
Intervention: Aquafresh Whitening Toothpaste with Fluoride
Number of subjects: 128
Study 11460611 — intervention group
Group type: COMPARATOR
Intervention: Crest Regular Fluoride Toothpaste
Number of subjects: 128
Study 9165969 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg tetrahydrocannabinol daily in five doses during active weeks
Number of subjects: 1
Study 9165969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 1389952 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IPB) 240 micrograms
Number of subjects: 0
Study 1389952 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IPB) 120 micrograms
Number of subjects: 0
Study 1389952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10273957 — intervention group
Group type: EXPERIMENTAL
Intervention: Practitioner-initiated minimal-contact intervention
Number of subjects: 213
Study 10273957 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 213
Study 10273957 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 213
Study 29895679 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term intervention (STI) with 2 training sessions
Number of subjects: 38
Study 29895679 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term intervention (LTI) with a 14-week gradual transition
Number of subjects: 38
Study 29895679 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 38
Study 27934805 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 400 µg/day for 2 months
Number of subjects: 85
Study 27934805 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 400 µg/day for 2 months
Number of subjects: 85
Study 25374052 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture (8-0 vicryl sutures)
Number of subjects: 90
Study 25374052 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 90
Study 25374052 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous in situ blood coagulum
Number of subjects: 90
Study 22522750 — intervention group
Group type: EXPERIMENTAL
Intervention: Watch PAT monitoring
Number of subjects: 56
Study 20234138 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal feeding tube (5-Fr) for 12 hours
Number of subjects: 32
Study 20234138 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral feeding tube (5-Fr) for 12 hours
Number of subjects: 32
Study 18926145 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
Number of subjects: 0
Study 18926145 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrower composite CV outcomes
Number of subjects: 0
Study 18926145 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended composite CV outcomes
Number of subjects: 0
Study 16095140 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for house dust mites (HDMs)
Number of subjects: 0
Study 16095140 — intervention group
Group type: COMPARATOR
Intervention: Untreated atopic patients
Number of subjects: 0
Study 16095140 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 15456073 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative tracking of the trunk using magnetic sensors
Number of subjects: 40
Study 15456073 — intervention group
Group type: EXPERIMENTAL
Intervention: Positioning on the Relton-Hall frame
Number of subjects: 40
Study 11034945 — intervention group
Group type: EXPERIMENTAL
Intervention: Genome-wide scan with 420 markers (353 microsatellites and 67 restriction fragment length polymorphisms) for systolic BP
Number of subjects: 206
Study 11034945 — intervention group
Group type: EXPERIMENTAL
Intervention: Genome-wide scan with 420 markers
Number of subjects: 206
Study 8932660 — intervention group
Group type: EXPERIMENTAL
Intervention: High Anger-out subscale (AOS) men during recovery
Number of subjects: 63
Study 8932660 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Anger-out subscale (AOS) women during recovery
Number of subjects: 63
Study 8932660 — intervention group
Group type: EXPERIMENTAL
Intervention: Men who expressed much anger during harassment
Number of subjects: 63
Study 8932660 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who expressed little anger during harassment
Number of subjects: 63
Study 8932660 — intervention group
Group type: EXPERIMENTAL
Intervention: High AOS men and low AOS women
Number of subjects: 63
Study 1539743 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination with formalin‐killed Rickettsia rickettsii
Number of subjects: 51
Study 1539743 — intervention group
Group type: COMPARATOR
Intervention: Challenge with Rickettsia rickettsii
Number of subjects: 51
Study 1539743 — intervention group
Group type: EXPERIMENTAL
Intervention: Postvaccination LT response
Number of subjects: 51
Study 1539743 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin tests using killed R. rickettsii as antigen
Number of subjects: 51
Study 2865153 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 14
Study 2865153 — intervention group
Group type: COMPARATOR
Intervention: Lipophilic beta-blockers (metoprolol and propranolol)
Number of subjects: 14
Study 30868496 — intervention group
Group type: EXPERIMENTAL
Intervention: Early partial weightbearing (Group A)
Number of subjects: 42
Study 30868496 — intervention group
Group type: COMPARATOR
Intervention: Delayed weightbearing (Group B)
Number of subjects: 42
Study 29746426 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonablative fractional 1565-nm Er:glass laser
Number of subjects: 20
Study 29746426 — intervention group
Group type: EXPERIMENTAL
Intervention: Picosecond fractional 1064/532-nm Nd:YAG laser
Number of subjects: 20
Study 27098066 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 20min)
Number of subjects: 20
Study 27098066 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study 25487353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate care in nursing home unit with increased staff and multidisciplinary assessment for a maximum stay of three weeks
Number of subjects: 376
Study 25487353 — intervention group
Group type: COMPARATOR
Intervention: Usual care in hospital
Number of subjects: 376
Study 22795881 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative music intervention for 30 minutes before surgery
Number of subjects: 60
Study 22795881 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 60
Study 22795881 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative music intervention
Number of subjects: 60
Study 20388196 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatekeeper training (QPR)
Number of subjects: 11000
Study 20388196 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness training on mental health promotion for adolescents
Number of subjects: 11000